AARD
Aardvark Therapeutics, Inc. Common Stock$3.92-0.12 (-2.97%)Prev Close$4.04·MCap$132.6M·P/E—·Vol105.0K·Yield—
▲
Buys (12M)
5
$450.3K
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$450.3K
●
Active Insiders
2
last 12 mo
Over the past 12 months, insider activity at Aardvark Therapeutics, Inc. Common Stock (AARD) has been exclusively buying, with 5 insider purchases totaling $450.3K and 0 insider sales totaling $0.00. The most recent insider transaction was by Lee Tien-Li (Chief Executive Officer), who purchased $101.4K worth of shares on Dec 11, 2025. Aardvark Therapeutics, Inc. Common Stock operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $132.6M.
AARD Insider Trading Activity
AARD Insider Buying Activity
The following table shows recent insider purchases of Aardvark Therapeutics, Inc. Common Stock (AARD) stock reported via SEC Form 4 filings.
AARD Insider Selling Activity
The following table shows recent insider sales of Aardvark Therapeutics, Inc. Common Stock (AARD) stock reported via SEC Form 4 filings.
No insider selling activity found for AARD in the last 12 months.